ClinicalTrials.gg
RecruitingNCT06457373Updated Aug 18, 2026

Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation

An interventional study of Demineralized Dentin Allograft and Demineralized Dentin Autograft in Alveolar Bone Loss, sponsored by Horus University. Recruiting at 1 site in Egypt. Open to participants aged 25 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Horus University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Alveolar Bone Loss with a site in Egypt — 22 open to participants now, 27 under way, none of them phase 3. Alveolar Bone Loss · Egypt.

Planned enrollment
8th of 74
40 · median 20
Started
2026
with 8 others
No phase
68 of 75
19 open now
Primary completion
2027-08
later than 26 of 26 live
Registered
38th of 75
by date

Among the 75 studies in Alveolar Bone Loss with a site in Egypt, this one is the 8th largest by planned enrollment of the 74 interventional ones that give a count, is one of 9 that started in 2026, is one of 68 with no phase, reaches primary completion later than 26 of the 26 other live ones, and was the 38th registered.

Alveolar Bone Loss

320 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.

Browse Alveolar Bone Loss studies →

Open to participants now

22 of the 75 studies in Alveolar Bone Loss with a site in Egypt are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.

This study: 25 Years to 35 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Alveolar Bone Loss with a site in Egypt, or all of them as a file.
02

Study summary

This study is designed to evaluate and compare clinically and radiographically the effectiveness of Demineralized Dentin Allograft (DDA) versus Demineralized Dentin Autograft (Auto-DD) for preservation of alveolar ridge dimensions after surgical extraction of the impacted mandibular third molar.

03

Conditions studied

  • Alveolar Bone Loss

Browse trials for

Keywords

  • Socket preservation
  • Impacted mandibular third molar
  • Alveolar ridge Augmentation
04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged between 25 to 35 years old.
  2. Patients scored as ().
  3. No adverse habits such as smoking, tobacco chewing, alcohol.
  4. Patients having bilaterally impacted mandibular third molar with similar degree of difficulty according to (Kim JY, et al).
  5. The recipient alveolar sockets are free of any pre-existing periapical pathology, based on x-ray.
  6. Alveolar sockets with a depth of 5 mm or more, using periodontal probe for assessment.
  7. Patients sign a consent for all procedures.

Exclusion criteria

Exclusion Criteria:

  • 1) Pregnant or lactating patients. 2) Relevant systemic diseases. 3) Patients with history of chemotherapy or radiotherapy.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Group A

    20 sockets will be grafted with Demineralized Dentin Allograft (DDA)

    Procedure: Demineralized Dentin Allograft

  • Active comparator
    Group B

    20 sockets will be grafted with Demineralized Dentin Autograft (Auto-DD)

    Procedure: Demineralized Dentin Autograft

Interventions

  • ProcedureDemineralized Dentin Allograft

    20 sockets are randomly allocated to receive the Demineralized Dentin Allograft (split-mouth study)

    Also known as: DDA

  • ProcedureDemineralized Dentin Autograft

    20 sockets are randomly allocated to receive the Demineralized Dentin Autograft (split-mouth study)

    Also known as: Auto-DD

06

What researchers measure

Primary outcomes

  1. Measuring and comparing the height of bone between the two groups

    We will measure the height of the alveolar ridge clinically by using ridge mapping caliper (special caliper forceps used for measuring ridge dimensions) and radiographically on the cone-beam computed tomography (CBCT) and comparing the results of the study group (20 sockets) with the control group (the other 20sockets), to assess the effectiveness of Demineralized Dentin Allograft for ridge preservation

    Time frame: Immediately post-operative, 3months post-operative, 6months post-operative

  2. Measuring and comparing the width of bone between the two groups

    We will measure the width of the alveolar ridge clinically by using ridge mapping caliper (special caliper forceps used for measuring ridge dimensions) and radiographically on the cone-beam computed tomography (CBCT) and comparing the results of the study group (20 sockets) with the control group (the other 20sockets), to assess the effectiveness of Demineralized Dentin Allograft for ridge preservation

    Time frame: Immediately post-operative, 3months post-operative, 6months post-operative

Secondary outcomes

  1. Assess and comparing the mouth opening of both groups

    Assess the mouth opening of the patient using a millimeter ruler (by measuring the distance between maxillary incisal edge and mandibular incisal edge) and comparing the results of both groups

    Time frame: One day post-operative, one week post-operative

  2. Assess and comparing the swelling of both groups

    Swelling levels after surgery will be measured using anatomic landmarks (Tragus-Labial commissure and Tragus-Pogonion), the distances between the landmarks used for the evaluation methods will be measured before the operation. All measurements will be done using millimeter ruler, while the patient will be seated.

    Time frame: One day post-operative, one week post-operative

  3. Assess and comparing the pain of both groups

    we will use the Visual Analogue Scale (VAS) for pain measurement

    Time frame: One day post-operative, one week post-operative

  4. Assess and comparing the soft tissue parameters (bleeding on probing and color of the gingiva) of both groups

    The bleeding on probing will be assessed by using periodontal probe and this will be done around mandibular first and second molars

    Time frame: One day post-operative, one week post-operative

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Joshi CP, D'Lima CB, Samat UC, Karde PA, Patil AG, Dani NH. Comparative Alveolar Ridge Preservation Using Allogenous Tooth Graft versus Free-dried Bone Allograft: A Randomized, Controlled, Prospective, Clinical Pilot Study. Contemp Clin Dent. 2017 Apr-Jun;8(2):211-217. doi: 10.4103/ccd.ccd_147_17. PubMed 28839405 ↗
  • Grover V, Kapoor A, Malhotra R, Sachdeva S. Bone allografts: a review of safety and efficacy. Indian J Dent Res. 2011 May-Jun;22(3):496. doi: 10.4103/0970-9290.87084. PubMed 22048602 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Aug 2027, 11 months after the start.

Of 169 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 11 months is below that.

Counting every sponsor, half of 169 studies reached it within 18 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2024
First posted
Jun 13, 2024
StartActual
Aug 13, 2026
Primary completionEst.
Aug 1, 2027
CompletionEst.
Aug 30, 2027
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06457373
Lead sponsor
Horus University
Responsible party
Mohamed Ali Habib (Oral and maxillofacial surgery clinical demonstrator, Horus University) — Principal investigator
First posted
Jun 13, 2024
Start date
Aug 13, 2026
Primary completion
Aug 1, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Aug 18, 2026

Study contacts

Mohamed Habib, B.D.S
Contact
mbasiouny@horus.edu.eg
+2001069505336
Ahmed Khalil, PHD
Contact
akhalil@horus.edu.eg
+2001005062045
Mohamed Habib, B.D.S
principal investigator · Faculty of Dentistry- Horus University in Egypt
Ahmed Khalil
study director · Faculty of Dentistry- Horus University in Egypt
Eman Abdelsalam
study director · Faculty of Dentistry- Horus University in Egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion